监测高血压患者盐摄入量的社区干预:一个集群随机对照试验
Pitchaporn Sonuch1, Wichai Aekplakorn2, Nophatee Pomsanthia3
1Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
PloS one
|November 22, 2024
概括
在高血压患者中,联合干预显著降低了缩血压和盐摄入量. 这种综合性方法显示出对社区一级血压和的降低有希望.
科学领域:
- 心血管健康 心血管健康
- 公共卫生干预 公共卫生干预
- 饮食研究 饮食研究
背景情况:
- 过度摄入是导致高血压和心血管疾病的主要原因.
- 减少饮食盐是具有挑战性的,因为人们的意识很低,盐度的口味值很高.
- 高血压影响了相当一部分成年人群,需要有效的管理策略.
研究的目的:
- 评估联合干预对高血压成年人盐摄入量和血压的有效性.
- 为了比较一个多方面的干预 (教育,食品再配方,环境变化,盐量计) 与单独的标准教育.
主要方法:
- 一个集群随机对照试验,涉及219名高血压成年人 (18-70岁) 在泰国.
- 参与者被随机分配到干预组 (n=111) 或对照组 (n=108).
- 干预措施包括密集的饮食教育,食品再配方,环境变化和盐度计的使用.
主要成果:
- 与对照组 (-9.5 mmHg) 相比,干预组显示系统血压显著降低 (-13.5 mmHg,P=0.030).
- 干预组中观察到尿液24小时内分泌量减少的趋势 (-575毫克/天 vs. -299毫克/天).
- 干预组的饮食盐摄入量显著改善,显示了两组之间的统计学上显著差异 (P=0.035).
结论:
- 综合干预有效降低了高血压患者的缩血压.
- 该干预表明,尿液中分泌量减少的积极趋势.
- 涉及教育,食品和环境的综合战略有利于降低社区的血压和盐摄入量.
相关概念视频
01:23Assessment of blood pressure in brachial artery(two-step method)
656
Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
656
01:18Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
01:28Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
01:25Errors occurring during blood pressure monitoring
604
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
604
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
455
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
455
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386